Posts in tag

Ozempic


Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …

Test of two separate imports showed they contained no semaglutide As the Ozempic shortage continues at least until the end of June, the Therapeutic Goods Administration (TGA) has detected counterfeit …

Two opposing forces lobbied for different ways to save patients money this week, while there was lots of medicines news and we looked at burnout in hospitals There was bad …

Just when you thought supplies were improving, sponsor and TGA now foresee supply problems until end of June 2023 It was a brief respite but now much-hyped diabetes and more-often-than-not …

Australians looking to access supplies of diabetes medication Ozempic (semaglutide) are being urged not to source the drug online  Patients turning to Google to find supplies of Ozempic are putting …

Double dispensing, pharmacist prescribing and women in pharmacy were all key issues which made the news this week We heard that some health practitioners have had their details stolen in …

One pharmacy stakeholder is worried that some prescribers’ identities have been stolen to make an Ozempic scam look more convincing And pharmacists concerned the same could have happened to them …

As shortage eases, regulator tells consumers to only deal with Australian pharmacies when buying the medicine The Therapeutic Goods Administration (TGA) has warned consumers to only obtain the shortage-plagued diabetes …

The TGA has announced that supplies of Ozempic (semaglutide) have begun being distributed—but pharmacies will have to be subject to purchasing limits Following skyrocketing demand for Ozempic due at least …

Shortages of diabetes medication, Ozempic (semaglutide), fueled by off-label prescribing of it as a weight-loss treatment, highlight the need for new drugs to tackle obesity.   With supplier, Novo Nordisk …

Ongoing global shortages of diabetes medication, Ozempic (semaglutide), due to off-label prescribing has prompted one patient to start a GoFundMe campaign for his funeral.   Diabetes patient, Stephen Callaghan, is …

Will Eli Lilly’s potential blockbuster get the same social media weight-loss attention as shortage plagued Ozempic? The next generation of Type-2 diabetes drugs – and by extension weight-loss drugs – …